The ingredients are processed in a unique and proprietary manner to increase the bioavailability of the active ingredients. The Sebrium DCD™ potentiates the CBD in the body and maximizes the overall therapeutic benefits.
These ingredients are used in the proprietary formula:
- Hemp Oil Extract
- Sebrium DCD™
- MCT Oil
- Natural Mixed Tocopherols
- Rice Bran Oil
- Carob (added as light barrier)
- Vegetable Glycerin
- Caramel Color
- Purified Water
Certified and FDA Approved Facilities.
In order to increase the effectiveness of the CBD in MiralonCBD, the CBD is put through a proprietary nano-emulsion process which creates ultra-tiny micelles of CBD. This process effectively suspends the CBD in water like tiny bubbles inside a big raindrop. The water-soluble micelle is a mimetic structure, meaning that it mimics the body’s own emulsification process and structure and allows the body to deliver the nano CBD structure directly into the small intestine. The active CBD is therefore homogeneously delivered to the intestinal wall for release into the bloodstream for maximum bioavailability and absorption into the blood plasma. Furthermore, these nano-sized molecules are attracted to the endocannabinoid system (ECS) in the brain/immune systems to achieve unparalleled efficacy. For comparison, the hemoglobin protein in the body is approximately 5 nanometers in diameter, so we are making CBD tiny bubbles that are within the same size range as the proteins in the human body.
Sebrium DCD™, the other active ingredient in MiralonCBD, is Sceletium Tortuosum (natural plant matter) that is uniquely processed through a process called dynamic cellular disruption. This process breaks up the plant matter without the use of chemicals, enzymes or blades.
Through this process, Sebrium DCD™ is able to achieve 3% potency of the active alkaloids. This is the only water-soluble version of Sebrium that enables great bioavailability and absorption. Sebrium is indigenous to South Africa and is from a succulent plant. The plant has shown applications in promoting a sense of wellbeing and relieving stress in healthy individuals and supporting anxiety and depression.
MiralonCBD is manufactured and processed exclusively by Molecular Health Technologies.
Molecular Health is committed to maintaining the highest quality standards and protocols, while continuing to optimize the efficacy and delivery of the ingredients we offer to the natural products marketplace. Our customers can attest that we constantly strive to accomplish our mission of servicing them with intelligence, innovation, and integrity.
Molecular Health Technologies LLC. is an incomparable supplier of the highest-quality commodity bulk raw ingredients as well as innovative, science-based, trademarked and patented compounds for the nutraceutical, beverage, and functional food markets. With over 50 years of combined experience encompassing formulations, global sourcing, manufacturing, marketing and distribution, Molecular Health is able to offer turn-key solutions to suit our customer’s needs. Powered by a consultative approach, we strive not only to understand, but to satisfy the needs of our clients. We create customized solutions that encompass innovative products, cutting-edge technologies, and novel delivery systems for each and every one of our customers.
Molecular Health plays an integral role in facilitating the development novel, clinically-studied ingredients, for condition-specific categories such as:
- Weight Loss
- Sports & Energy
- Joint Health
- Joint Health
- Men’s and Women’s Health and Enhanced Sexual Function
- Cardio Health / Immune Function
- Cognitive Health / Memory / Sleep Function
- Enhanced Bioavailable Products
Bringing actual scientific data into the equation.
40 retired NFL players participated in a clinical study conducted by a renowned sports medicine physician at the NY Hospital of Special Surgery. The study was done to see if Miralon could be proven to relieve pain. All of the participants in the study reported pain relief and reduced usage of NSAIDs, opioids and anti-inflammatory medications.
More Studies on THC and CBD.
Brightfield Group – From Farm to Aisle
A 2019 report on the U.S. CBD Market
World Health Organization – CBD Critical Review Report
A 2018 study on Cannabidiol (CBD)